The generation of transgenic pigs as potential organ donors for humans

1. Cooper, D.K.C., Ye, Y., Rolf, J.L.L. & Zuhdi, N. The pig as potential organ donor for man in Xenotransplantation: The Transplantation of Organs and Tissues Between Species (eds Cooper, D.K.C., Kemp, E., Reemtsma, K. & White, D.J.G.) 481−500 (Springer, Berlin, 1991).
2. Calne, R.Y. Organ transplantation between widely disparate species. Transplants Proc. 2, 550−553 (1970). | ChemPort |
3. Sachs, D.H. & Bach, F.H. Immunology of xenograft rejection. Hum. Immun. 28, 245−251 (1990). | Article | PubMed  | ISI | ChemPort |
4. Dalmasso, A.P. et al. Mechanisms of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140, 1157−1166 (1992). | PubMed  | ISI | ChemPort |
5. Johnston, P.S., Wang, M.W., Lim, S.M., Wright, L.J. & White, D.J. Discordant xenograft rejection in an antibody-free model. Transplantation 54, 573−576 (1992). | PubMed  | ISI | ChemPort |
6. Platt, J.L. et al. Immunopathology of hyperacute rejection in a swine to primate model. Transplantation 52, 214−220 (1991). | PubMed  | ISI | ChemPort |
7. Kemp, E., Kemp, G., Starklint, H. & Larsen, S. Immunosuppression with cobra venom factor, anti-platelet aggregator, and cyclosporin A in renal xenotransplantation. Transplantn Proc. 14, 116 (1982).
8. Braidley, P.C., Dunning, J.J., Wallwork, J. & White, D.J.G. Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs. Transplantn Proc. 26, 1259−1260 (1994). | ChemPort |
9. Leventhal, J.R. et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55, 857−865 (1993). | PubMed  | ISI | ChemPort |
10. Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363−370 (1994). | PubMed  | ISI | ChemPort |
11. Lachmann, P.J. The control of homologous lysis. Immun. Today. 12, 312−315 (1991). | PubMed  | ISI | ChemPort |
12. Atkinson, J.P., Odlesby, T.J., White, D.J.G., Adams, E.A. & Liszewski, M.K. Separation of self from non self in the complement system. A role for membrane cofactor protein and decay accelerating factor. Clin. exp. Immun. 86, 27−30 (1991). | PubMed  | ChemPort |
13. Oglesby, T.J., Allen, C.J., Liszewski, M.K., White, D.J. & Atkinson, J.P. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J. exp. Med. 175, 1547−1551 (1992). | PubMed  | ISI | ChemPort |
14. White, D.J.G. et al. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant. Int. 5, 648−650 (1992).
15. Dalmasso, A.P., Vercelloti, G.M., Platt, J.L. & Bach, F.H. Inhibition of complement mediated cytotoxicity by decay accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52, 530−533 (1991). | PubMed  | ISI | ChemPort |
16. Cary, N., Moody, J., Yannoutsos, N., Wallwork, J. & White, D. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: A potential approach to inhibition of hyperacute xenograft rejection. Transplantn Proc. 25, 400−401 (1993). | ChemPort |
17. Diamond, L. et al. Cell and tissue specific expression of a human CD59 minigene in transgenic mice. Transplantn Proc. 26, 1239 (1994). | ChemPort |
18. Rosengard, A.M. et al. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs — a potential approach for preventing xenograft rejection. Transplantation 59, 1325−1333 (1995). | PubMed  | ISI | ChemPort |
19. Fodor, W.L. et al. Expression of a functional human complement inhibitor in transgenic swine as an approach to prevent xenogeneic hyperacute organ rejection. Proc. natn. Acad. Sci. USA. 91, 11153−11157 (1994). | ChemPort |
20. Miyagawa, S. et al. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium. Transplantn Proc. 26, 1253−1254 (1994). | ChemPort |
21. Walsh, L.A., Tone, M. & Waldmann, H. Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement. Eur. J. Immun. 21, 847−850 (1991). | ISI | ChemPort |
22. Charreau, B. et al. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation 58, 1222−1229 (1994). | PubMed  | ISI | ChemPort |
23. Van den Berg, C.W. & Morgan, B.P. Complement-inhibiting activities of human CD59 and analogues from rat, sheep and pig are not homologously restricted. J. Immun. 152, 4095−4101 (1995).
24. Langford, G.A. et al. Production of pigs transgenic for human decay accelerating factor. Transplantn Proc. 26, 1400−1401 (1994). | ChemPort |
25. White, D.J.G., Langford, G.A., Cozzi, E. & Young, V.J. Protective effects of human DAF in transgenic pigs. Xeno (in the press).
26. McCurry, K.R. et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1, 423−427 (1995). | Article | PubMed  | ISI | ChemPort |
27. Bach, F.H. et al. Discordant xenografting: A working model of problems and issues. Xeno 1, 8−15 (1993).
28. Cooper, D.K.C., Koren, E. & Oriol, R. Oligosaccharides and discordant xenotransplantation. Immunol. Rev. 141, 31−58 (1994). | PubMed  | ISI | ChemPort |
29. Sandrin, M.S., Vaughan, H.A. & McKenzie, I.F.C. Identification of Gal(l−3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplantn Rev. 8, 134−149 (1994).
30. Yannoutsos, N. et al. Production of pigs transgenic for human regulators of complement activation. Transplantn Proc. 27, 324−325 (1995). | ChemPort |

	Top

	Top